Streetbeat News

Stock Prices

Hecla Mining has reported an 8% increase in silver production year-to-date (YTD), but a 14% decrease in gold production. The company's stock symbol is HL.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 10:06 am

SUI

Sun Communities Inc (SUI) has divested approximately 10.25% interest in Ingenia Communities Group, selling about 41.8 million shares for a minimum net proceeds of $100 million. The company had extended its joint venture partnership with Ingenia in August 2023 for another seven years. SUI's Q3 2023 results are expected on October 25, 2023.

Portfolio Pulse from Lekha Gupta

October 12, 2023 | 10:04 am

AKRO

BCS

DAO

ETWO

FNGR

PLNT

SHCR

Several stocks recorded losses in Thursday's pre-market trading session. Youdao, Inc. (DAO) shares fell 8.1%, E2open Parent Holdings, Inc. (ETWO) shares dipped 4.1% following a downgrade from Redburn Atlantic analyst Alex Haissl, FingerMotion, Inc. (FNGR) shares declined 4.1%, Planet Fitness, Inc. (PLNT) shares fell 3.6%, Barclays PLC (BCS) shares declined 3.5%, Sharecare, Inc. (SHCR) shares tumbled 3.4% after a preliminary non-binding proposal for acquisition, and Akero Therapeutics, Inc. (AKRO) fell 3% following a 36-week analysis of a Phase 2b study.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 9:58 am

CARR

Wolfe Research analyst Nigel Coe has downgraded Carrier Global (NYSE:CARR) from Peer Perform to Underperform and set a price target of $56.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 9:31 am

JKHY

Goldman Sachs analyst Will Nance has downgraded Jack Henry & Associates (NASDAQ:JKHY) from Neutral to Sell and set a price target of $140.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 9:00 am

FFND

LLY

NVO

Eli Lilly & Co.'s stock continues to surge due to the potential of its GLP-1 drug Mounjaro, currently used for Type 2 diabetes treatment. The drug is expected to receive FDA approval for obesity treatment by year-end. Fund Manager Gary Black estimates that if Mounjaro captures 30% of the $100 billion GLP-1 market, it could generate $10 billion in revenue for Lilly by 2025. Morgan Stanley analyst Terence Flynn raised his price target for Lilly to $673.

Portfolio Pulse from Shanthi Rexaline

October 12, 2023 | 8:40 am

NTST

Keybanc analyst Todd Thomas has downgraded Netstreit (NYSE:NTST) from Sector Weight to Underweight and set a price target of $13.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 8:27 am

DA Davidson analyst Gil Luria has upgraded Dynatrace (NYSE:DT) from Neutral to Buy and raised the price target from $50 to $65.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 8:09 am

NVDA

Analysts at TD Cowen have revised their price target for Nvidia Corporation (NASDAQ:NVDA) to $700 from the previously projected $600, suggesting a potential 50% stock gain. The analysts maintain an Outperform rating on Nvidia, citing the company's superior technology, innovation, and growth-oriented investments as reasons for the optimistic outlook.

Portfolio Pulse from Benzinga Neuro

October 12, 2023 | 8:06 am

CERE

DAL

DPZ

VSCO

WBA

Walgreens Boots Alliance, Cerevel Therapeutics Holdings, Delta Air Lines, Victoria's Secret & Co., and Domino's Pizza are the stocks to watch heading into Thursday. Walgreens is expected to report quarterly earnings of 69 cents per share on revenue of $34.82 billion. Cerevel Therapeutics has priced its public offering of 19,728,189 shares at $22.81 per share. Delta Air Lines is expected to have earned $1.94 per share on revenue of $14.54 billion. Victoria's Secret has reaffirmed its full-year 2023 guidance and expects an adjusted loss of 70 cents to 90 cents per share for the third quarter. Domino's Pizza is expected to report quarterly earnings of $3.30 per share on revenue of $1.05 billion.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 7:59 am